Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Clinical trial NCT05844982 · RECRUITING
Trial details
- NCT number
- NCT05844982
- Sponsor
- Jaeb Center for Health Research
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2029-12-26
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.